KCNQ1 rs2237895 polymorphism is associated with the therapeutic response to sulfonylureas in Iranian type 2 diabetes mellitus patients.
Siavash ShakerianHomeira RashidiMaryam Tahmasebi BirganiAlihossein SaberiPublished in: Journal of diabetes and metabolic disorders (2022)
rs2237895 polymorphism is associated with the sulfonylureas response on Iranian type 2 diabetes patients.